Novozymes, a provider of biological solutions, agreed to acquire a majority stake in Synergia Life Sciences, a manufacturer of chemicals and chemical products, pharmaceuticals and botanical products, for $150m. "Novozymes’ strong presence in the functional foods and dietary supplement space makes this a strategic fit for Synergia’s innovative product portfolio. We are very excited to be part of the Novozymes family," Dilip Mehta, Synergia Life Sciences CEO.